Top

World Journal of Surgery

Published in:

01-06-2009

Intraoperative Blood Loss is a Critical Risk Factor for Peritoneal Recurrence After Curative Resection of Advanced Gastric Cancer

Authors: Takao Kamei, Joji Kitayama, Hiroharu Yamashita, Hirokazu Nagawa

Published in: World Journal of Surgery | Issue 6/2009

Abstract

Background

Perioperative blood transfusion has been shown to be associated with poor outcome in various types of malignancy. However, the relationship between the amount of blood loss and specific types of cancer recurrence has not been documented.

Methods

We retrospectively examined the amount of intraoperative blood loss and the recurrence pattern in 146 patients who underwent curative gastrectomy for advanced gastric cancer and assessed the possible correlation between intraoperative blood loss and peritoneal, locoregional, and hematogenous recurrences.

Results

The amount of intraoperative blood loss in patients who developed peritoneal recurrence was significantly greater than that in patients without peritoneal recurrence, irrespective of blood transfusion. In contrast, the blood loss was not associated with nodal or hematogenous recurrence. Multivariate analysis demonstrated that large blood loss as well as operative curability B and adjuvant chemotherapy were independent risk factors for peritoneal recurrence and a worse outcome in advanced gastric cancer.

Conclusions

Intraoperative blood loss in curative gastrectomy for advanced gastric cancer may have a specific association with the development of peritoneal recurrence. Surgeons must remember that clean and dry surgery may lessen not only 30-day mortality and morbidity but long-term peritoneal recurrence in gastric cancer.

Burrows L, Tartter P (1982) Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 2(8299):662PubMedCrossRef

Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M (1994) Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115:303–309PubMed

Donohue JH, Williams S, Cha S, Windschitl HE, Witzig TE, Nelson H, Fitzgibbons RJ Jr, Wieand HS, Moertel CG (1995) Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol 13:1671–1678PubMed

Rzyman W, Dziadziuszko R, Skokowski J, Wilimski R, Raiter A, Szymanowska A, Jassem J (2003) The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J Thorac Cardiovasc Surg 126:755–760PubMedCrossRef

Jagoditsch M, Pozgainer P, Klingler A, Tschmelitsch J (2006) Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 49:1116–1130PubMedCrossRef

Hyung WJ, Noh SH, Shin DW, Huh J, Huh BJ, Choi SH, Min JS (2002) Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 9:5–12PubMedCrossRef

Choi JH, Chung HC, Yoo NC, Lee HR, Lee KH, Kim JH, Roh JK, Min JS, Lee KS, Kim BS et al (1995) Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer. Oncology 52:170–175PubMed

Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Abad JM, Vicente R, Aranda F, Lujan JA, Parrilla P (1997) Does perioperative blood transfusion influence long-term prognosis of gastric cancer? Dig Dis Sci 42:2072–2076PubMedCrossRef

Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW (1994) Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 12:1859–1867PubMed

10.

Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Watanabe R, Kohno H, Nagasue N (2000) Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg 24:588–594PubMedCrossRef

11.

Association JGC (1998) Japanese classification of gastric cancer. Gastric Cancer 1:10–24

12.

Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–1119PubMedCrossRef

13.

Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef

14.

D’Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240:808–816PubMedCrossRef

15.

Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K (2000) Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 87:353–357PubMedCrossRef

16.

Schwarz RE, Zagala-Nevarez K (2002) Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 9:394–400PubMedCrossRef

17.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, ACTS-GC Group (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820PubMedCrossRef

18.

Bruns CJ, Schafer H, Wolfgarten B, Engert A (1996) Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract. Langenbecks Arch Chir Suppl Kongressbd 113:146–149PubMed

19.

McCourt M, Wang JH, Sookhai S, Redmond HP (1999) Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 134:1325–1331PubMedCrossRef

20.

Seo KH, Ko HM, Choi JH, Jung HH, Chun YH, Choi IW, Lee HK, Im SY (2004) Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. Eur J Immunol 34:2129–2137PubMedCrossRef

21.

Bottles KD, Laszik Z, Morrissey JH, Kinasewitz GT (1997) Tissue factor expression in mesothelial cells: induction both in vivo and in vitro. Am J Respir Cell Mol Biol 17:164–172PubMed

22.

Fernandez PM, Patierno SR, Rickles FR (2004) Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 30:31–44PubMed

Title: Intraoperative Blood Loss is a Critical Risk Factor for Peritoneal Recurrence After Curative Resection of Advanced Gastric Cancer
Authors: Takao Kamei
Joji Kitayama
Hiroharu Yamashita
Hirokazu Nagawa
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 6/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-009-9979-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Intraoperative Blood Loss is a Critical Risk Factor for Peritoneal Recurrence After Curative Resection of Advanced Gastric Cancer

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2009

Significance of Biochemical Parameters in Differentiating Uniglandular from Multiglandular Disease and Limiting Use of Intraoperative Parathormone Assay

Laparoscopic Monitored Colonoscopic Polypectomy: Long-Term Follow-Up

Intrahepatic Cholangiocarcinoma: Prognostic Factors After Surgical Resection

Tensiometry as a Decision Tool for Abdominal Wall Reconstruction with Component Separation

Universal Precautions and Surgery in Sierra Leone: The Unprotected Workforce

Reply